Baxter ExactaMix Inlets Recalled for Particulate Contamination Risk
Baxter Healthcare is recalling ExactaMix pharmaceutical compounding device inlets due to increased reports of particulate matter in the sterile fluid path before use. The recall involves 2,140,046 units with worldwide distribution.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I recall. Per the rubric, FDA Class I medical device recalls have a minimum severity score of 4 (Severe), regardless of whether illnesses have been reported.
Plain-English summary
Baxter Healthcare Corporation is recalling the EXACTAMIX Inlet, Vented, Syringe Inlet (REF H938176 and related product codes), used in ExactaMix and ExactaMix Pro pharmaceutical compounding devices. Lot Numbers 803807 and lower are included in this recall.
The company has received increased customer reports of particulate matter found within the inlet components, specifically in the sterile fluid path tubing, observed before use. The inlets are disposable components designed for use in pharmaceutical compounding applications.
Approximately 2,140,046 units have been distributed worldwide. Healthcare facilities and pharmacies using these compounding devices should verify whether their inlets are from the affected lot numbers (803807 and lower, UDI/DI 00085412475813).
Healthcare providers should contact Baxter Healthcare Corporation immediately for instructions on handling affected inlets and potential replacement options. Users should not use affected inlets in compounding operations.
The recalled product
- Product
- Baxter EXACTAMIX Inlet, Vented, Syringe Inlet, REF H938176, for use in a pharmaceutical compounding device
- Manufacturer
- Baxter Healthcare Corporation
- Affected units
- 2,140,046
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- UDI/DI 00085412475813
- Lot Numbers: 803807 and lower
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 4 recalled by Baxter Healthcare Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Baxter Healthcare Corporation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Dexmedetomidine Hydrochloride Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Same hazard · particulate contamination
See all →- CriticalCardiovascular Procedure Kits Recalled Due to Particulate in Fluid Path
FDA (Devices) · 2026-08-05
- HighLidocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateFDA Recalls Xylocaine Injections Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- SevereMedline Medical Convenience Kits with Namic Manifold Fluid Contamination
FDA (Devices) · 2026-05-20
- SevereMedline Medical Convenience Kits with Namic Manifold recalled
FDA (Devices) · 2026-05-20